Author:

• Lia Hasenclever - Hasenclever, L. - UFRJ, Instituto de Economia - <lia@ie.ufrj.br>
ORCID: https://orcid.org/0000-0003-1384-6323

Co-author(s):

• Diego Vieira - Vieira, Diego - Universidade Federal do Rio de Janeiro, Instituto de Economia - <diegofvieira@hotmail.com>
• Cintia Reis Costa - Costa, Cintia Reis - Universidade Federal do Rio de Janeiro, Instituto de Economia - <cintiareiscosta@hotmail.com>
• Julia Paranhos - Paranhos, Julia - Universidade Federal do Rio de Janeiro, Instituto de Economia - <juliaparanhos@ie.ufrj.br>
ORCID: https://orcid.org/0000-0003-4425-7484
• Gabriel Cunha - Cunha, Gabriel - Universidade Federal do Rio de Janeiro, Instituto de Economia - <gabrielfgcunha@gmail.com>

Thematic Area:

Não Categorizado

Abstract:

The purpose of this article is to discuss and analyze the development challenges of the medicinal plants and phytotherapics industry in Brazil. This industry is an excellent alternative to address the paradox of plenty in the health area. The adopted methodology was a field research through semi structured questionnaires with companies, researchers and public managers to evaluate their development between 2009 and 2015 and to point out the main problems. The observed results indicate that the main challenges in the research area is the regulation of the law on access to genetic patrimony and in the production area is the harmonization of the rules throughout the production chain of medicinal plants and phytotherapics. The slow implementation pace of public policies for the industry shows a setback both of productive and research activities with medicinal plants and phytotherapics in the period.

Keywords:

Medicinal PlantsPhytotherapicsIndustryRegulationAccess to Genetic Patrimony

Content:

Access Issue in Scielo

Other languages: